Friday, February 17, 2017

Cannabis - Is it useful for Prostate Cancer?

The PAF began getting reports from men about their cannabis use for prostate cancer a number of years ago. Clinical research on the subject is still hard to find. So the PAF does not encourage or discourage the use of cannabis for prostate cancer treatment. However, a number of men with prostate cancer have reported using a protocol of very high concentrated cannabis oil called Rick Simpson Oil (RSO). The protocol calls for using 1 gram of this cannabis oil per day for between 90 and 180 days depending on the severity of the disease and whether you have had prior conventional treatment.
PAF devoted a lecture and meeting to the subject of cannabis and prostate cancer this February.
Here are some of the things we learned from men in attendance :
1) A number of men we met are currently using variations on this protocol.
2) Some men with early stage prostate cancer report using 250mg instead of 1 gram of RSO.
3) To avoid the extreme psycho-activity at this volume of consumption a number of men are using RSO in suppository form. This approach by-passes the liver on the first pass which dramatically reduces the stony effect. Men report being able to tolerate these large doses and still function and remain focused thru the day.
4) After taking RSO orally for about a week or so, most men report a diminishment of the psycho-active effect.
5) Men on these protocols report deeper and more restful sleep with a pronounced reduction in BPH symptoms including reduced night time urinary frequency.
6) One man with a Gleason of 8 and recurrent prostate cancer after radiation therapy was told by his cancer specialists after a full battery of tests including an MRI and PET scans that his prostate cancer could not be found. But yet his PSA has continued to rise!
We know these stories are not clinical research, but the results are certainly encouraging and bear watching.
 .

Monday, February 6, 2017

If You Have Prostate Cancer You Probably Won't Die From It!

That's right, only 3 % of men diagnosed with prostate cancer die from it. I like to say it the other way around: 97% of men diagnosed with prostate cancer will not die from it. So what will most of us die from? More than likely a heart attack.
I had a wake up call over the holidays. My younger brother called me from the hospital. He had had a massive heart attack. At 62 he had had no prior heart problems, but when he called he told me that if he had not called 911 when he did he would not be here today. The type of heart attack he had is called a Widow Maker. It is a major blockage of the left artery in the heart. The name speaks for itself. The survival rate is very low. I realized I need to get a better understanding.  So I Googled Widow Maker to learn more and hopefully find out what I might to do avoid one myself.
Keep in mind that the pro-active lifestyle changes I adopted to keep my prostate cancer from progressing back in 1995 are also important for heart health. They include a prostate healthy diet, lots of cardiovascular exercise and stress management.
But I wanted to do something more. It turns out that Vitamin K2 is a very important supplement for heart health. It helps put calcium where it belongs: in the bones not in the arteries where a calcium build up can lead to a clogging of the arteries and a heart attack.
So I bought a year's supply of Vitamin K2 from a reputable supplier for under $100. In my opinion
very inexpensive additional insurance against heart disease.
Check it out!

Friday, January 13, 2017

Mt Shasta 2017 Cancer Climb and Trek for Prostate Awareness

Happy New Year.
Would you believe that Mt Shasta beat it's previous world record for the most snow at one time..
18' in 4 days, 22' in 7 days. That's a lot of snow.
A group of PAF hikers on a snowshoe expedition visited Mt Shasta just before Christmas on a scouting expedition. This was right before the big snowfall.
Awesome.

We will be summiting 14,179' Mt Shasta in July during the PAF's annual
Cancer Climb and Trek for Prostate Awareness.
Want to join the expedition?
For details contact Ken Malik @ 415-407-3961 or kamalik@prostateawarenessfoundation.org



Tuesday, June 7, 2016

Dying with Dignity in California

By the end of this week California will become the 5th state in the USA to allow a terminally ill person to legal take their own life with the approval of 2 doctors who verify they have 6 months or less to live, are mentally competent and can administer a lethal pharmaceutical themselves. 
Whether u agree morally with this issue or not we think having this option available is important and will eliminate much pain and suffering when appropriate. 

Thursday, March 17, 2016

Bill Kortum Memorial Hike

Join the Prostate Awareness Foundation on Saturday (March19th) to pay homage to Bill Kortum one of California's pioneer environmentalists on the trail named after him. Bill passed away from advanced prostate cancer in 2014.
Meet at Shell Beach on Hwy 1 on the Sonoma coast @ 11am

Wednesday, January 6, 2016

Aspirin found to stall prostate cancer progression

Men diagnosed with prostate cancer who took 3 aspirins a week had a 24% lower risk of developing lethal cancer, and a 39% reduced risk of dying from the disease.
"It was after the diagnosis that there appeared to be a benefit" says Christopher Allard a Urology fellow at Harvard Medical School lead author of the study.
A word of caution: be careful of gastro-intestinal problems with aspirin!

Wednesday, December 16, 2015

Prostate Cancer Drug Treatment Leads to Alzheimers!

ADT (androgen deprivation therapy) is a relatively new drug therapy for prostate cancer that cuts off the bodies ability to make testosterone.
We at the PAF have been suspicious of this chemical castration therapy since it became a common protocol in the mid 1990's.
ADT side effects are regularly reported by members of the PAF and include hot flashes, calcium deficiency, fatigue, loss of libido and memory impairment.
Now a new study published in the Journal of Clinical Urology this December ties ADT to a higher incidence of Alzheimer's disease.
This study of 2400 men for two decades by the University of Pennsylvania and Stanford University surprised the researchers.
Men on ADT in the study had an 88% higher risk of getting Alzheimers. In fact those men on testosterone blockade for over 1 year increased their Alzheimers Risk by more than double those men who did not use this protocol.
We feel that the risk of debilitating Alzheimers outweigh the benefits of ADT
What do you think?
We suggest asking your oncologist his position on this provocative study.
ADT has become the treatment path of choice for men with advanced prostate cancer!